Oxford Immunotec
Entry
2007
Hold
14yr
Exit
2021
Who owns Oxford Immunotec?
Oxford Immunotec was owned by Wellington Partners through Wellington Partners Life Sciences (1998 vintage) from 2007 to 2021, exited via Trade Sale.
Buyer identity available on Pro.
Hand-verified · updated 2026-08-10
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2021
More from Wellington Partners Life Sciences
Other portfolio companies in the same fund.
United States
AustriaMore PE-backed in MedTech
Comparable medtech deals from other GPs.
Optos
Exited 2015
Amadeus Capital Partners
UK
UKto
Axomove
Active
Go Capital
France· 2026
France· 2026Bioliberty
Active
Scottish National Investment BankUK· 2026
UK· 2026CertHub
Active
Cusp Capital Partners
Germany· 2026
Germany· 2026Clee Medical
Active
High-Tech Gruenderfonds (HTGF)
Switzerland· 2026
Switzerland· 2026CollimateHealth
Active
Caesar Ventures ManagementGermany· 2026
Germany· 2026Track Oxford Immunotec
Save this record to your watchlist and pick up your research where you left off. No spam.
Get the full record on Oxford Immunotec.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue